Journal of Endocrinological Investigation

, Volume 14, Issue 3, pp 173–179 | Cite as

Thyrotropin-releasing hormone: further extraction studies and analysis by fast protein liquid chromatography and radioimmunoassay

  • Leonidas Duntas
  • F. S. Keck
  • D. Grouselle
  • J. Rosenthal
  • C. Wolf
  • E. F. Pfeiffer


We describe the clinical application of a radioimmunoassay combined with fast protein liquid Chromatography (FPLC) for measuring TRH immunoreactivity (TRH-IR) in blood samples extracted previously with methanol or with Sep Pak C18 cartridges. Sensitivity of the RIA was 3 fmol/tube, displacement at 50% B/B0 was achieved by 55 fmol of unlabelled TRH. Our specific antibody K2B7 (km = 2.2 fM) showed no cross reaction with other peptides. No difference was observed between the mean values of TRH-IR in 19 euthyroid, 22 hyperthyroid, 18 hypothyroid and 10 hypophysectomised patients (45 ± 17.8, 58 ± 30, 40 ± 22 and 36 ± 12 fmol/ml, mean ± SD, respectively), whereas TRH-IR was significantly lowered (p < 0.05) in 6 euthyroid pancreatectomised patients (21 ± 5 fmol/ml). The reversed phase FPLC analysis of the TRH-IR presented in the methanol extracts was shown to have the same retention time as synthetic TRH. TRH could not be measured in unextracted blood samples. TRH added in preincubated (60 min, at 37 C), before extraction, blood samples showed a loss of 83.4% of immunoreactivity. Our results demonstrate that this method is able to detect TRH-IR in human blood by whole methanol extraction and/or by Sep Pak C18 cartridges extraction. Furthermore the findings suggest that the main source of circulating TRH-IR may be of extrahypothalamic (pancreatic?) origin and that the basal peripheral TRH levels are not involved or they do not clearly represent a pathological condition.


TRH-IR peripheral TRH RIA reversed phase chromatography FPLC 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Guigner F., Pelletier C., Tonzery C., Guillard P. Thyrotropin releasing hormone radioimmunoassay in human serum and its application in thyroidal pathology. Eur. J. Nucl. Med. 6: 73, 1981.Google Scholar
  2. 2.
    May P., Donabedian R.K. A sensitive radioimmunoassay for thyrotropin releasing hormone. Clin. Chim. Acta 46: 371, 1973.PubMedCrossRefGoogle Scholar
  3. 3.
    Oliver C., Charret S.P., Codaccioni S.L., Vague J. Radioimmunoassay of thyrotropin releasing hormone (TRH) in human plasma and urine. J. Clin. Endocrinol. Metabol. 39: 406, 1974.CrossRefGoogle Scholar
  4. 4.
    Saito S., Musa K., Yamamoto S., Oshima I., Funato T. Radioimmunoassay of thyrotropin releasing hormone in plasma and urine. Endocrinol. Jpn. 22: 303, 1975.PubMedCrossRefGoogle Scholar
  5. 5.
    Emerson C.H., Utiger R.F. Plasma thyrotropin releasing hormone concentration in the rat. J. Clin. Invest. 56: 1564, 1975.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Vale W., Burgus R., Dunn T.F., Guillemin R. In vitro plasma inactivation of thyrotropin releasing factor (TRH) and related peptides. Its inhibition by various means and by the synthetic dipeptide PCA-HIS-OME. Hormones 2: 193, 1971.PubMedCrossRefGoogle Scholar
  7. 7.
    Visser T.J., Klootwijk W. Approaches to a markedly increased sensitivity of the radioimmunoassay for thyrotropin releasing hormone by derivatization. Biochim. Biophys. Acta 673: 454, 1981.PubMedCrossRefGoogle Scholar
  8. 8.
    Mallik T.K., Wilber I.F., Pegues I. Measurements of thyrotropin releasing hormone in human peripheral blood by affinity chromatography and radioimmunassay. J. Clin. Endocrinol. Metab. 54: 1194, 1982.PubMedCrossRefGoogle Scholar
  9. 9.
    Chen Y.F., Ramirez V.D. Production and characterization of antisera to synthetic thyrotropin releasing hormone (TRH). J. Histochem. Cytochem. 30: 926, 1982.PubMedCrossRefGoogle Scholar
  10. 10.
    Iversen E. Thyrotropin-releasing hormone cannot be detected in plasma from normal subjects. J. Clin. Endocrinol. Metab. 63: 516, 1986.PubMedCrossRefGoogle Scholar
  11. 11.
    Hunter W., Greenwood F.C. Preparation of iodine 131 labelled human growth hormone of high specific activity. Nature 194: 494, 1962.CrossRefGoogle Scholar
  12. 12.
    Grouselle D., Faivre-Baumann A., Tixier-Vidal A. A radioimmunoassay for thyroliberin (TRH): comparison with a TRH-radioreceptor assay. Neurosci. Lett. 7: 7, 1978.PubMedCrossRefGoogle Scholar
  13. 13.
    Bassiri R.M., Utiger D. The preparation and specificity of antibody to thyrotropin-releasing-hormone. Endocrinology 90: 722, 1972.PubMedCrossRefGoogle Scholar
  14. 14.
    Mosse J., Baudet J. Fractionation of sun-flower seed proteins. J. Amer. Oil Chem. Soc. 54: 82, 1977.CrossRefGoogle Scholar
  15. 15.
    Jeffcoate S.L., White N. Use of benzamidine to prevent the destruction of thyrotropin-releasing hormone (TRH) by blood. J. Clin. Endocrinol. Metab. 38: 155, 1974.PubMedCrossRefGoogle Scholar
  16. 16.
    Bassiri R., Utiger R.D. Serum inactivation of the immunological and biological activity of the thyrotropin releasing hormone (TRH). Endocrinology 91: 657, 1972.PubMedCrossRefGoogle Scholar
  17. 17.
    Mitsuma T. Radioimmunoassay of thyrotropin releasing hormone in human serum and its clinical application. Acta Endocrinol. (Copenh.) 83: 225, 1976.Google Scholar
  18. 18.
    Utiger R.D., Bassiri R. Thyrotropin-releasing hormone (TRH) radioimmunoassay. In: Gual C. and Rosenberg E. (Eds.), Hypothalamic Hypophysotopic Hormones. Excerpta Medica, Amsterdam, 1973, p. 146.Google Scholar
  19. 19.
    Eskay R., Oliver C., Warberg S., Porter S. Inhibition of degradation and measurement of immunoreactive thyrotropin releasing hormone in rat blood and plasma. Endocrinology 98: 269, 1976.PubMedCrossRefGoogle Scholar
  20. 20.
    Nett T.M., Adams T.E. Further studies on the radioimmunoassay of gonadotropin-releasing hormone: effect of radioiodination, antiserum and unextracted serum on levels of immunoreactivity in serum. Endocrinology 101: 1135, 1977.PubMedCrossRefGoogle Scholar
  21. 21.
    Lombardi G., Panza N., Cei S., Cosimato F., Minozzi M. Radioimmunoassay of thyrotropin releasing hormone (TRH) in normal subjects, in abnormal thyroid states and under catecholaminergic influences. Acta Endocrinol. (Copenh.) 87: 70, 1978.Google Scholar
  22. 22.
    Moncayo R., Duntas L. Demonstration of TRH, its metabolite diketopiperazine and the analogue MK771 by means of Fast Protein Liquid Chromatography (FPLC) and radioimmunoassay of TRH in blood. J. Endocrinol. Invest. (Suppl. 3) 8: 169, 1985.Google Scholar
  23. 23.
    Suhonen A.-S., Leppälmoto J., Salmi J. Urine TRH-immunoreactivity in hypothyroid and hyperthyroid patients. Acta. Endocrinol. (Copenh.) 105: 482, 1984.Google Scholar
  24. 24.
    Suhonen-Mahn A.S., Leppäluoto J., Kiviniemi H., Larmi T. Increased urinary levels of thyrotropin-releasing hormone immunoreactivity in acute pancreatitis. Scand. J. Gastroenterol. 20: 559, 1985.CrossRefGoogle Scholar
  25. 25.
    Gullo L., Labo G. Thyrotropin-releasing hormone inhibits pancreatic enzyme secretion in humans. Gastroenterology 80: 735, 1981.PubMedGoogle Scholar
  26. 26.
    Kiviniemi H., Laitinen S., Stahlberg M., Larmi M., Kairalnoma M. Thyrotropin-releasing hormone in acute pancreatitis Acta Chir. Scand. 152: 43, 1986.Google Scholar
  27. 27.
    Oystein L., Kristian D., Hassen F. Thyrotropin-releasing hormone immunoreactivity in gastrointestinal tract of man. J. Clin. Endocrinol. Metab. 56: 524, 1983.CrossRefGoogle Scholar
  28. 28.
    Leppaeluoto J., Koivusalo F., Kraama R. Thyrotropin-releasing factor: distribution in neural and gastrointestinal tissues. Acta Physiol. Scand. 104: 175, 1978.CrossRefGoogle Scholar
  29. 29.
    Yanagisawa N., Fujimoto S., Short term effect of TRH on disability in steptracking movement in spinocerebellar degeneration. Annual Report of the Research Committee of Therapeutic Agents for Spinocerebellar Degenerations. Ministry of Health and Welfare of Japan, 1983, p. 188.Google Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1991

Authors and Affiliations

  • Leonidas Duntas
    • 1
  • F. S. Keck
    • 1
  • D. Grouselle
    • 2
  • J. Rosenthal
    • 1
  • C. Wolf
    • 1
  • E. F. Pfeiffer
    • 1
  1. 1.Abt. Innere Medizin I, Medizinische Klinik und Poliklinik UlmUniversität UlmUlmGermany
  2. 2.Groupe de Neuroendocrinologie CellulaireCollege de FranceParisFrance

Personalised recommendations